|
Daehan New Pharm Co., Ltd. Turns Profit, Achieving Significant Growth with 23% Increase in Sales and 82% Increase in Operating Profit
2011.05.11
|
|---|
|
Daehan New Pharm Co., Ltd. achieved a profit turnaround with a 23% increase in sales to 12,736 million KRW and an 82% significant growth in operating profit to 1,459 million KRW (operating profit margin 11.5%). Although net income was in deficit in Q4 2010, it turned positive to 418 million KRW in Q1 2011.
This remarkable improvement in Daehan New Pharm's performance is attributed to the successful implementation of key strategic tasks, including product structure enhancement, distribution structure improvement, sales force strengthening, organizational revitalization, and rigorous profitability-focused responsible management activities.
The company has been enhancing its product portfolio by focusing and specializing on core products such as obesity and vitamin treatments, and shifting distribution strategy to direct transactions, which continuously improves its competitiveness. |


Home